Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Alantar A, et al. Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res. 2011;63:1126.
Amiche MA, et al. Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses. J Bone Miner Res. 2018;33:419–29.
Anbiaee N, et al. Early diagnosis of progressive systemic sclerosis (scleroderma) from a panoramic view: report of three cases. Dentomaxillofac Radiol. 2011;40:457–62.
Antonarakis SE, et al. Down syndrome. Nat Rev Dis Primers. 2020;6:9.
Ardic F, et al. The comprehensive evaluation of temporomandibular disorders seen in rheumatoid arthritis. Aust Dent J. 2006;51:23–8.
Arnet I, et al. Methotrexate intoxication: the pharmaceutical care process reveals a critical error. J Clin Pharm Ther. 2012;37:242.
Asarch A, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol. 2009;61:104–11.
Auluck A, et al. Mandibular resorption in progressive systemic sclerosis: a report of three cases. Dentomaxillofac Radiol. 2005;34:384–6.
Ayouni I, et al. Comorbidity between fibromyalgia and temporomandibular disorders: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128:33–42.
Bahareh Bakhshaie P. Dysphagia - pathophysiology of swallowing dysfunction, symptoms, diagnosis and treatment. J Otolaryngol Rhinol. 2019;5:63.
Balasubramaniam R, et al. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:204–16.
Barbe AG. Medication-induced xerostomia and hyposalivation in the elderly: culprits, complications, and management. Drugs Aging. 2018;35:877.
Baron R, et al. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011;48:677–92.
Baron M, et al. Relationship between disease characteristics and oral radiologic findings in systemic sclerosis: results from a Canadian Oral Health Study. Arthritis Care Res. 2016;68:673.
Bauer DC, et al. Bisphosphonate drug holidays in primary care: when and what to do next? Curr Osteoporos Rep. 2021;19:182–8.
Benli M, et al. Orofacial manifestations and dental management of systemic lupus erythematosus: a review. Oral Dis. 2021;27:151.
Bessa-Nogueira RV, et al. Targeted assessment of the temporomandibular joint in patients with rheumatoid arthritis. J Oral Maxillofac Surg. 2008;66:1804–11.
Bodet C, et al. Synergistic effects of lipopolysaccharides from periodontopathic bacteria on pro-inflammatory cytokine production in an ex vivo whole blood model. Mol Oral Microbiol. 2010;25:102–11.
Borzutzky A, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012;130:e1190–7.
Brennan MT, et al. Oral manifestations of patients with lupus erythematosus. Dent Clin N Am. 2005;49:127–41, ix.
Bridges MJ, et al. Raynaud’s phenomenon affecting the tongue of a patient with scleroderma. Ann Rheum Dis. 2002;61:472.
Brown PM, et al. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol. 2016;12:731.
Buch K, et al. Chronic non-bacterial osteomyelitis: a review. Calcif Tissue Int. 2019;104:544–53.
Buckley L, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69:1521–37.
Campbell FA, et al. Scalp necrosis in temporal arteritis. Clin Exp Dermatol. 2003;28:488–90.
Campisi G, et al. Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int J Environ Res Public Health. 2020;17:5998.
Campos DES, et al. Is there an association between rheumatoid arthritis and bone changes in the temporomandibular joint diagnosed by cone-beam computed tomography? A systematic review and meta-analysis. Clin Oral Investig. 2021;25:2449–59.
Chatterjee S. Raynaud phenomenon causing lingual pallor and dysarthria. Can Med Assoc J. 2016;188:E396–6.
Chen Z, et al. Bone inflammation and chronic recurrent multifocal osteomyelitis. Eur Rev Med Pharmacol Sci. 2018;22:1380–6.
Conklin RJ, et al. Oral lichen planus. Dermatol Clin. 1987;5:663–73.
Corsalini M, et al. Evidence of signs and symptoms of craniomandibular disorders in fibromyalgia patients. Open Dent J. 2017;11:91–8.
Crincoli V, et al. Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study. Int J Mol Sci. 2016;17:1189.
Damm DD, et al. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays. Gen Dent. 2013;61:33–8.
Davatchi F. Diagnosis/classification criteria for Behcet’s disease. Pathol Res Int. 2012;2012:607921.
De Bleecker JL, et al. 205th ENMC International Workshop: pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25:268.
Deeming GMJ, et al. Methotrexate and oral ulceration. Br Dent J. 2005;198:83–5.
Del Rosso A, et al. Oral health in patients with systemic sclerosis. Rheumatology. 2014;53:1355–6.
Delantoni A, et al. Osteolysis affecting the jaws in systemic sclerosis: clinical and osseous changes based on a case presentation. Clin Med Insights Arthritis Musculoskelet Disord. 2015;8:CMAMD.S30510.
Desbois AC, et al. Systemic sclerosis: an update in 2016. Autoimmun Rev. 2016;15:417.
Dimopoulos MA, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol. 2009;20:117–20.
Dodson TB. The frequency of medication-related osteonecrosis of the jaw and its associated risk factors. Oral Maxillofac Surg Clin North Am. 2015;27:509–16.
El Assar de la Fuente S, et al. Juvenile idiopathic arthritis and the temporomandibular joint: a comprehensive review. J. Craniomaxillofac Surg. 2016;44:597–607.
Elshebini E, et al. Assessment of nutritional deficiency manifestations in patients with rheumatic diseases. Egypt Rheumatol. 2021;43:167–71.
Erciyas K, et al. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis. 2013;19:394.
Ertekin C, et al. Orophaxryngeal dysphagia in polymyositis/dermatomyositis. Clin Neurol Neurosurg. 2004;107:32.
Eyigör S. Dysphagia in rheumatological disorders. World J Rheumatol. 2013;3:45.
Fernández-de-las-Penas C, et al. Myofascial temporomandibular disorder. Curr Rheumatol Rev. 2016;12:40–54.
Ferreli C, et al. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol. 2017;53:306–36.
Fortuna G, et al. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review. Eur J Clin Pharmacol. 2017;73:1523–37.
Fraga BP, et al. Signs and symptoms of temporomandibular dysfunction in fibromyalgic patients. J Craniofac Surg. 2012;23:615–8.
Furness S, et al. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev. 2013;8:CD009603.
Galli F, et al. Role of psychological factors in burning mouth syndrome: a systematic review and meta-analysis. Cephalalgia. 2017;37:265–77.
Galli J, et al. Upper dysphagia in patients affected by systemic sclerosis: prevalence and features. Acta Otorhinolaryngol Ital. 2020;40:204–10.
Girschick HJ. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64:279–85.
Glick M. Clinical aspects of recurrent oral herpes simplex virus infection. Compend Contin Educ Dent. 2002;23:4.
Goupille P, et al. The temporomandibular joint in rheumatoid arthritis. Correlations between clinical and computed tomography features. J Rheumatol. 1990;17:1285.
Grant S, et al. Giant cell arteritis affecting the tongue: a case report and review of the literature. Dent Update. 2013;40:669–77.
Grbic JT, et al. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid. J Am Dent Assoc. 2010;141:1365–70.
Greco A, et al. Behçet’s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17:567.
Gualtierotti R, et al. Main oral manifestations in immune-mediated and inflammatory rheumatic diseases. J Clin Med. 2018;8:21.
Guarneri V, et al. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat. 2010;122:181–8.
Gupta A, et al. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841–6.
Hagiya H, et al. Oral shingles. BMJ Case Rep. 2018;11:228383.
Hamel J, et al. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int. 2012;32:555–6.
Hanisch M, et al. Gingival hyperplasia as first sign of recurrence of granulomatosis with polyangiitis (Wegener’s granulomatosis): case report and review of the literature. BMC Oral Health. 2016;17:33.
Harrison P. Plaque control and oral hygiene methods. J Ir Dent Assoc. 2017;63:151–6.
Hatemi G, et al. 2018 Update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;77:808.
Helenius LMJ, et al. Clinical and radiographic findings of the temporomandibular joint in patients with various rheumatic diseases. A case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:455–63.
Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15.
Hernández G, et al. Strawberry-like gingival tumor as the first clinical sign of Wegener’s granulomatosis. J Periodontol. 2008;79:1297.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
Hofmann SR, et al. Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment. Curr Osteoporos Rep. 2017;15:542–54.
Hsieh Y-J, et al. Facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe temporomandibular joint involvement. Am J Orthod Dentofac Orthop. 2016;149:182–91.
Hügle B, et al. Isolated arthritis of the temporomandibular joint as the initial manifestation of juvenile idiopathic arthritis. J Rheumatol. 2017;44:1632–5.
Ishii E, et al. Oral mucositis and salivary methotrexate concentration in intermediate-dose methotrexate therapy for children with acute lymphoblastic leukemia. Med Pediatr Oncol. 1989;17:429–32.
Janssen KMJ, et al. Lessons to be learned from periodontitis. Curr Opin Rheumatol. 2013;25:241.
Jansson H, et al. Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontol. 2006;33:408.
Jenkins P. Lingual infraction in cranial arteritis. Dent Update. 1985;12:303–5.
Jones GT, et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015;67:568–75.
Jonsson R, et al. Oral mucosal lesions in systemic lupus erythematosus--a clinical, histopathological and immunopathological study. J Rheumatol. 1984;11:38–42.
Jung S, et al. The spectrum of orofacial manifestations in systemic sclerosis: a challenging management. Oral Dis. 2017;23:424.
Kalantzis A, et al. Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:52.
Katsarelis H, et al. Infection and medication-related osteonecrosis of the jaw. J Dent Res. 2015;94:534–9.
Kaur S, et al. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013;92:399.
Kharazmi M, et al. Oral ulcers, a little known adverse effect of alendronate: review of the literature. J Oral Maxillofac Surg. 2012;70:830–6.
Kim SY, et al. Can denosumab be a substitute, competitor, or complement to bisphosphonates? Korean J Pain. 2017;30:86–92.
Klasser GD, et al. Burning mouth syndrome: a challenge for dental practitioners and patients. Gen Dent. 2011;59:210–2.
Ko EH, et al. Dysphagia due to inclusion body myositis: case presentation and review of the literature. Ann Otol Rhinol Laryngol. 2014;123:605.
Kremer JM, et al. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum. 1992;35:138–45.
Kroese J, et al. TMJ pain and crepitus occur early whereas dysfunction develops over time in rheumatoid arthritis. J Oral Facial Pain Headache. 2020;34:398–405.
Kuć J, et al. Evaluation of orofacial and general pain location in patients with temporomandibular joint disorder-myofascial pain with referral. Front Neurol. 2019;10:546.
Kunchur R, et al. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:1167–73.
Labeit B, et al. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med. 2020;9:2150.
Lamey PJ, et al. Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:44–9.
Leader DM. Scleroderma and dentistry: every dentist is a scleroderma specialist. J Mass Dent Soc. 2007;56:16–9.
Leader D, et al. A survey of dentists’ knowledge and attitudes with respect to the treatment of scleroderma patients. J Clin Rheumatol. 2014;20:189.
Lehman JS, et al. Atrophic glossitis from vitamin B 12 deficiency: a case misdiagnosed as burning mouth disorder. J Periodontol. 2006;77:2090–2.
Lengfeld J, et al. Bisphosphonate-mediated oral ulcers: a rare differential diagnosis of erosive oral lesions. Dermatology. 2016;232:117–21.
Lerman MA, et al. Pigmentation of the hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:8–12.
Lertpimonchai A, et al. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. Int Dent J. 2017;67:332–43.
Letsinger JA, et al. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol. 2005;52:500–8.
Lo JC, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68:243–53.
Lourenço SV, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol. 2007;34:558.
Malden N, et al. An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence. J Bone Miner Metab. 2012;30:171–82.
Marí A, et al. Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review. J Craniomaxillofac Surg. 2014;42:1990–6.
Marty M, et al. Recurrent aphthous stomatitis as a marker of celiac disease in children. Pediatr Dermatol. 2016;33:241–1.
Mays JW, et al. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract. 2012;12:265–82.
McCartan BE, et al. Oral lichenoid drug eruptions. Oral Dis. 1997;3:58–63.
McGowan K, et al. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions. Aust Dent J. 2018a;63:202–7.
McGowan K, et al. Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis. 2018b;24:527–36.
van de Meent MM, et al. Outcome of different treatments for chronic diffuse sclerosing osteomyelitis of the mandible: a systematic review of published papers. Br J Oral Maxillofac Surg. 2020;58:385–95.
Mignogna MD, et al. Unexplained somatic comorbidities in patients with burning mouth syndrome: a controlled clinical study. J Orofac Pain. 2011;25:131–40.
Missen GAK. Gangrene of the tongue. Br Med J. 1961;1:1393–4.
Moisset X, et al. Co-occurrence of pain symptoms and somatosensory sensitivity in burning mouth syndrome: a systematic review. PLoS One. 2016;11:e0163449.
de Molon RS, et al. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int J Mol Sci. 2019;20:4541.
Morr Verenzuela CS, et al. Burning mouth syndrome: results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levels—experience at Mayo Clinic over a decade. Int J Dermatol. 2017;56:952.
Muller L, et al. Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: a pilot study comparing clinical examination and ultrasound to magnetic resonance imaging. Rheumatology. 2009;48:680–5.
Muñoz-Corcuera M, et al. Oral ulcers: clinical aspects. A tool for dermatologists. Part I. acute ulcers. Clin Exp Dermatol. 2009;34:289–94.
Murakami S, et al. Dental plaque-induced gingival conditions. J Periodontol. 2018;89(Suppl 1):S17–27.
Nagpal R, et al. The two-way association of periodontal infection with systemic disorders: an overview. Mediat Inflamm. 2015;2015:793898.
Närhi TO, et al. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging. 1999;15:103.
Nazeri M, et al. Role of anxiety and depression in association with migraine and myofascial pain temporomandibular disorder. Indian J Dent Res. 2018;29:583–7.
Nicolatou-Galitis O, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:117–35.
Niibo P, et al. Contemporary management of TMJ involvement in JIA patients and its orofacial consequences. EPMA J. 2016;7:12.
O’Connor RC, et al. Management of the temporomandibular joint in inflammatory arthritis: involvement of surgical procedures. Eur J Rheumatol. 2017;4:151–6.
Orteu CH, et al. Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? Br J Dermatol. 2001;144:1219–23.
Ortiz Z, et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol. 1998;25:36–43.
Ottesen C, et al. Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon. 2020;6:e03795.
Otto S, et al. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: pain relief and insight into pathogenesis. J Craniomaxillofac Surg. 2015;43:1837–42.
Özçaka Ö, et al. Clinical periodontal status and inflammatory cytokines in primary Sjögren syndrome and rheumatoid arthritis. J Periodontol. 2018;89:959–65.
Ozcelik O, et al. The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:481.
Padwa BL, et al. Pediatric chronic nonbacterial osteomyelitis of the jaw: clinical, radiographic, and histopathologic features. J Oral Maxillofac Surg. 2016;74:2393–402.
Paraskevas KI, et al. Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences. Clin Rheumatol. 2007;26:1044.
Patel V, et al. New cancer therapies and jaw necrosis. Br Dent J. 2015;219:203–7.
Pedersen A, et al. Salivary functions in mastication, taste and textural perception, swallowing and initial digestion. Oral Dis. 2018;24:1399–416.
Petri M, Orbai AM, Alarcón G. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematous. Arthritis Rheum. 2012;64:2677–86.
Pierce JL, et al. Swallowing disorders in Sjögren’s syndrome: prevalence, risk factors, and effects on quality of life. Dysphagia. 2016;31:49–59.
Pimolbutr K, et al. Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-naïve patient: a comprehensive review of the literature. Biomed Res Int. 2018;2018:1–14.
Pischon N, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008;79:979.
Potts AJ, et al. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol. 1987;64:541–3.
Poveda-Roda R, et al. Temporomandibular disorders. A case-control study. Med Oral Patol Oral Cir Bucal. 2012;17:e794–800.
Pradeep S, et al. Giant cell arteritis: practical pearls and updates. Curr Pain Headache Rep. 2018;22:2.
Prior JA, et al. Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis. BMC Med. 2017;15:120.
Romano F, et al. Type 2 diabetes mellitus and periodontitis: are diabetic patients aware about this bidirectional association? Acta Diabetol. 2021;58:1277.
Rotondo C, et al. Mucocutaneous involvement in Behçet’s disease: how systemic treatment has changed in the last decades and future perspectives. Mediat Inflamm. 2015;2015:451675.
Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014;72:1938–56.
Ruggiero SL, et al. Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2015;73:S94–S100.
Russmueller G, et al. The association of medication-related osteonecrosis of the jaw with actinomyces spp. infection. Sci Rep. 2016;6:31604.
Rutter-Locher Z, et al. Association between systemic lupus erythematosus and periodontitis: a systematic review and meta-analysis. Front Immunol. 2017;8:1295.
Sandhu S, et al. Osteonecrosis of the jaw and dental extractions: a single-center experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130:515–21.
Savioli C, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012;18:180.
Savtekin G, et al. Rheumatoid arthritis in temporo-mandibular joint: a review. Niger J Clin Pract. 2018;21:1243–6.
Scarfe WC, et al. Clinical applications of cone-beam computed tomography in dental practice. J Can Dent Assoc (Tor). 2006;72:75.
Schmidt E, et al. Pemphigoid diseases. Lancet. 2013;381:320.
Schulz S, et al. Periodontal pathogens and their role in cardiovascular outcome. J Clin Periodontol. 2020;47:173.
Scully C, et al. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985;14:431–58.
Scully C, et al. Auto-inflammatory syndromes and oral health. Oral Dis. 2008;14:690.
Seo HW, et al. A case of rheumatoid nodules involving the larynx. Korean J Otorhinolaryngol Neck Surg. 2019;62:663–6.
Shea B, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol. 2014;41:1049.
Sheehan NJ. Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases. Rheumatology. 2008;47:746–52.
Sheldon CA, et al. Giant cell arteritis presenting with bilateral loss of vision and jaw pain: reminder of a potentially devastating condition. J Can Dent Assoc. 2011;77:b55.
Shiroky JB, et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1993;36:795.
Singh D, et al. Scleroderma: an insight into causes, pathogenesis and treatment strategies. Pathophysiology. 2019;26:103–14.
Skef W, et al. Gastrointestinal behçet’s disease: a review. World J Gastroenterol. 2015;21:3801.
Smirani R, et al. Orofacial consequences of systemic sclerosis: a systematic review. J Scleroderma Relat Disord. 2018;3:81–90.
Solomon DH, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303.
Szczeklik K, Włudarczyk A, Wawrzycka-Adamczyk K, et al. Oral manifestations of granulomatosis with polyangiitis - Clinical and radiological assessment. J Dent Sci. 2019;14(1):54–60.
Stoll ML, et al. Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what? Pediatr Rheumatol. 2018;16:32.
Tan HL, et al. Burning mouth syndrome: an update. Cephalalgia Rep. 2020;3:1–18.
Tejani S, et al. Candidal carriage predicts candidiasis during topical immunosuppressive therapy: a preliminary retrospective cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:448–54.
Teoh L, et al. A review and guide to drug-associated Oral adverse effects-Oral mucosal and lichenoid reactions. Part 2. J Oral Pathol Med. 2019;48:637–46.
Thomas BS, et al. Periodontal diseases and awareness among patients. Indian J Dent Res. 2005;16:103–8.
Thoua NM, et al. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology. 2010;49:1770–5.
Trackman PC, et al. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res. 2015;94:540–6.
Treister NS, et al. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:e1–4.
Tu TTH, et al. Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review. Biopsychosoc Med. 2019;13:1.
Tugal-Tutkun I, et al. Disease of the year: juvenile idiopathic arthritis-associated uveitis-classification and diagnostic approach. Ocul Immunol Inflamm. 2014;22:56.
Urman JD, et al. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum. 1978;21:58–61.
Veale BJ, et al. Orofacial manifestations of systemic sclerosis. Br Dent J. 2016;221:305.
Vedin O, et al. Periodontal disease in patients with chronic coronary heart disease: prevalence and association with cardiovascular risk factors. Eur J Prev Cardiol. 2015;22:771.
Velly AM, et al. The effect of fibromyalgia and widespread pain on the clinically significant temporomandibular muscle and joint pain disorders--a prospective 18-month cohort study. J Pain. 2010;11:1155–64.
Visser K, et al. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis. 2009;68:1094.
Wipff J, et al. A large National Cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67:1128–37.
Wolff A, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on Oral medicine VI. Drugs R D. 2017;17:1.
Wood RE, et al. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol. 1988;65:172–8.
Yamashita J, et al. Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract. 2012;12:233–47.
Youssef Mohamed MM, et al. Radiographic changes in TMJ in relation to serology and disease activity in RA patients. Dentomaxillofac Radiol. 2020;49:20190186.
Yuen HK, et al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012;34:84.
Yunus M. Editorial review (thematic issue: an update on central sensitivity syndromes and the issues of nosology and psychobiology). Curr Rheumatol Rev. 2015;11:70–85.
Zadik Y, et al. Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome. Quintessence Int. 2012;43:97–104.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Marino, S. et al. (2023). Oral Manifestations Associated with Rheumatic Diseases. In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-031-23488-0_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23487-3
Online ISBN: 978-3-031-23488-0
eBook Packages: MedicineMedicine (R0)